These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8416022)

  • 21. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effects of fluvoxamine on panic symptomatology.
    Pols H; Zandergen J; de Loof C; Fernandez I; Griez E
    Acta Psychiatr Belg; 1993; 93(3):169-77. PubMed ID: 8030430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
    den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks.
    van Megen HJ; Westenberg HG; den Boer JA; Slaap B; Scheepmakers A
    Psychopharmacology (Berl); 1997 Feb; 129(4):357-64. PubMed ID: 9085405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder.
    Black DW; Wesner R; Bowers W; Gabel J
    Arch Gen Psychiatry; 1993 Jan; 50(1):44-50. PubMed ID: 8422221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine.
    Sandmann J; Lörch B; Bandelow B; Härtter S; Winter P; Hiemke C; Benkert O
    Pharmacopsychiatry; 1998 Jul; 31(4):117-21. PubMed ID: 9754844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.
    van Vliet IM; den Boer JA; Westenberg HG; Slaap BR
    J Clin Psychopharmacol; 1996 Aug; 16(4):299-306. PubMed ID: 8835705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone.
    de Beurs E; van Balkom AJ; Lange A; Koele P; van Dyck R
    Am J Psychiatry; 1995 May; 152(5):683-91. PubMed ID: 7726307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives.
    Cameron OG; Smith CB; Nesse RM; Hill EM; Hollingsworth PJ; Abelson JA; Hariharan M; Curtis GC
    Psychosom Med; 1996; 58(4):289-301. PubMed ID: 8827791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noradrenergic and serotonergic function in posttraumatic stress disorder.
    Southwick SM; Krystal JH; Bremner JD; Morgan CA; Nicolaou AL; Nagy LM; Johnson DR; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1997 Aug; 54(8):749-58. PubMed ID: 9283511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled study.
    Perna G; Bertani A; Gabriele A; Politi E; Bellodi L
    J Clin Psychopharmacol; 1997 Jun; 17(3):173-8. PubMed ID: 9169961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM
    Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN; Vitton BJ; Uhde TW
    Psychiatry Res; 1997 Jun; 71(1):27-39. PubMed ID: 9247979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of short-term treatment response in 66 patients with panic disorder.
    Black DW; Wesner RB; Gabel J; Bowers W; Monahan P
    J Affect Disord; 1994 Apr; 30(4):233-41. PubMed ID: 8014323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety.
    Mizuki Y; Suetsugi M; Ushijima I; Yamada M
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov; 20(8):1353-67. PubMed ID: 9004342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
    Wylie ME; Miller MD; Shear MK; Little JT; Mulsant BH; Pollock BG; Reynolds CF
    J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.